The financial press is still in a full-court propaganda press on behalf of Big Pharma, I see.
Perhaps. And it wouldn't be a surprise. Judging even from the few responses here though, for now it does seem to be safer to err on the side of a brand-name version when it comes to prescription drugs. But over the counter items...or even supermarket-brand food items, there is more room for flexibility and may even be preferable to brand-name.
“The financial press is still in a full-court propaganda press on behalf of Big Pharma, I see.”
It’s funny because I am not one of the hysterics about evil big Pharma. That started out as leftist anti-capitalist attacks and seems now to have infected plenty of conservatives.
The funny part is that I agree with your comment above and that’s what I thought when I read this article.